Automata

Automata

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $57.5M

Overview

Automata is a private company offering a modular and software-defined lab automation platform called LINQ, which includes hardware (LINQ Bench), workflow design software (LINQ Canvas), and cloud-based orchestration. Its open architecture aims to break down legacy automation silos, allowing labs to integrate diverse instruments, execute parallel workflows, and connect with AI models for advanced data analysis. The company targets the growing demand for flexible, scalable automation in drug discovery, diagnostics, and digital health, with notable partnerships including The Royal Marsden NHS Foundation Trust and the Francis Crick Institute.

Drug DeliveryDigital Health

Technology Platform

LINQ platform: an open, integrated, AI-ready lab automation ecosystem comprising modular hardware (LINQ Bench), no-code/code workflow design software (LINQ Canvas & Python SDK), and a cloud-based orchestration & analytics layer (LINQ Cloud). It enables software-defined process orchestration, parallel workflow execution, and seamless integration with lab instruments and AI models.

Funding History

2
Total raised:$57.5M
Series B$50M
Series A$7.5M

Opportunities

The growing demand for flexible, modular automation to replace legacy systems in life science R&D and clinical diagnostics presents a major opportunity.
The convergence of lab automation with AI/ML, requiring high-quality, structured data generation, positions Automata's open, data-integration platform as a critical enabling infrastructure.

Risk Factors

Key risks include intense competition from established life science tool giants and other startups, the technical challenge of reliably integrating diverse instruments and software, and the long sales cycles associated with capital equipment in research and diagnostic settings.

Competitive Landscape

Automata competes in the lab automation market against large, integrated vendors like Thermo Fisher Scientific and Beckman Coulter Life Sciences, as well as specialized robotics firms. Its key differentiation is its open, software-defined, and highly configurable platform, which contrasts with the more closed, proprietary systems historically dominant in the field.